Next Article in Journal
Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies
Previous Article in Journal
Determinants of Prolonged Postoperative Length of Stay After Carotid Revascularization: A Single-Center Registry Analysis from Kazakhstan
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience

by
Philipp Tratnig-Frankl
,
Andrea Wiland
,
Christian Freystätter
,
Eva Placheta-Györi
and
Christine Radtke
*
Department of Plastic, Reconstructive and Aesthetic Surgery, Vienna General Hospital, Medical University of Vienna, 1090 Vienna, Austria
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2026, 15(17), 6549; https://doi.org/10.3390/jcm15176549
Submission received: 23 June 2026 / Revised: 17 August 2026 / Accepted: 18 August 2026 / Published: 25 August 2026

Abstract

Background: In recent years, the number of patients seeking body contouring surgeries after a single organ transplantation has increased due to better postoperative care, better immunosuppressive regimens and the advancement of laparoscopic bariatric surgical techniques. In these patients, body contouring procedures can improve function, aesthetics, and overall quality of life and are offered to a greater number of patients including cohorts with significant medical comorbidities such as immunosuppression after solid organ transplantation. Therefore, in this case series, we explored the topic of body contouring surgery in patients who underwent solid organ transplantation. Methods: In this retrospective study, we included patients who underwent a single organ transplantation prior to a body contouring surgery between 2010 and 2021. Inclusion criteria were age over 18 years, a body contouring surgery at our center, a single organ transplantation before the body contouring procedure and a postoperative follow up of four weeks or more. Results: A total of 422 patients underwent body contouring procedures in our center. After excluding non-eligible patients, four patients were recruited. Overall, four complications in three patients occurred, ranging from Grade I to II according to the Dindo and Clavien classification for surgical complications. Conclusions: Body contouring surgery seems to be safe in patients with single organ transplantation. However, careful patient selection in a multidisciplinary team is required to ensure patients’ safety and favorable postoperative outcomes in patients with extended operative indications and significant comorbidities such as solid organ transplantation and immunosuppression. Complex patients should be treated in close collaboration with transplant surgery and internal medicine at a tertiary center.

1. Introduction

The relationship between obesity and surgical complications is multifactorial and increasingly relevant given the rising prevalence of obesity among surgical patients with increased risk of certain surgical complications, most notably surgical site infections, venous thromboembolism, and renal complications [1,2,3,4,5]. On the other hand, the numbers of liver and kidney transplantation have increased, with a total of 1659 liver transplantations and 28,142 kidney transplantations in the United States in 2023 [6,7]. Common indications for liver transplantation are non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatocellular carcinoma (HCC) and alcohol-related liver disease (ALD) [8,9,10,11,12]. On the other hand, the most common causes of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) are diabetes and hypertension, which account for the majority of patients requiring dialysis or kidney transplantation [13,14,15,16].
Especially obese patients, defined by a body mass index (BMI) ≥ 30 kg/m2, have higher risks of developing metabolic disorders and are therefore prone to organ dysfunctions [17,18,19]. In order to minimize the complications of obesity and its comorbidities, bariatric surgery (BS) has become a validated surgical option for treating obesity in patients suffering from end-stage renal disease, decreasing the percentage of graft failure in organ recipients and reducing the burden of comorbidities [20,21,22]. Body contouring surgeries are intended to excise loose or excessive skin, which is often a result after bariatric surgical procedures [23].
It has to be taken into consideration that from a non-surgical point of view, body contouring procedures (e.g., abdominoplasty) have been associated with significant improvements in psychosocial outcomes and body image, as quantified by validated instruments such as the BODY-Q [24,25]. However, post-bariatric patients were found to have higher rates of postoperative complications after body contouring procedures, including surgical side infections, seroma formation and prolonged wound healing in up to 42.9% of patients, compared to 12.6% in a non-bariatric cohort [26]. In the past, patients that were primarily not considered for single organ transplantation (SOT) because of their comorbidities are now given further surgical options in order to become possible candidates for SOT [20,27,28]. For surgical planning, it has to be considered that each abdominal surgery impairs the blood supply of the abdominal wall as scarring interrupts the zones of perfusion, which may deteriorate wound healing in subsequent surgeries [29,30].
With increasing survival rates, organ recipients are seeking body contouring surgeries as well, which can be challenging due to their history of transplantation [31].
The aim of this study was the assessment of perioperative complications in patients with body contouring surgeries after single organ transplantation.

2. Materials and Methods

Patients treated with surgery for body contouring at a tertiary academic plastic surgery department between January 2010 and September 2021 were included in this retrospective, monocentric study. In total, 592 body contouring surgeries were performed in 422 patients. Of these patients, four (n = 4) had a body contouring procedure after the single organ transplantation. Patients with an incomplete medical history were excluded from this study.

2.1. Patients

Patients’ demographics, comorbidities, transplanted organ, immunosuppressive maintenance regimens, length of hospital stay, and postoperative course were assessed. The classification proposed by Dindo et al. for surgical complications was used to assess patient outcomes [32]. All patients were carefully evaluated preoperatively in a multidisciplinary setting involving internal medicine specialists and transplant surgeons. This assessment included a thorough review of graft function and viability. At the time of the BCP, patient #3 was totally weaned off his immunosuppressive medication, patient #1 and patient #2 had a monotherapy (either FK-506 or Cyclosporine-A), and one (patient #4) continued being on triple immunosuppression.

2.2. Statistical Analysis

Descriptive statistical analysis was performed for all assessed data, such as patient demographics, bariatric procedures, weight loss, BCP, SOT and postoperative complications. Microsoft ExcelTM (version 16.27, 2019 Microsoft Corporation, Redmond, WA, USA) was used for statistical analysis.

3. Results

A total of four patients (n = 4) were included (Table 1): one female and three male patients with a mean age of 46 years (range: 28 to 56 years). Apart from having a SOT, all male patients underwent a gastric sleeve procedure before they were referred to our clinic for BCP. The female patient did not have any bariatric surgery. The mean preoperative weight was 73.25 kg (range: 61 to 83 kg), while the preoperative body mass index (BMI) was 25.2 (range: 22.3 to 28.4).
Transplanted organs included two liver, one heart and a kidney transplantation. Most of our patients had a minimum of three comorbidities, including arterial hypertension or diabetes. The time period between the SOT and their BCP was on average 6.6 years (range: 3.1 to 9.0 years).

3.1. Body Contouring Procedures

The male patients had an abdominal dermolipectomy, due to concerns about further harming the blood supply of the abdominal wall after liver or kidney transplantation (Figure 1). The female patient underwent a bilateral thigh lift (Table 2). The intraoperative resection weights were 1200, 1084 and 380 g in the male patients and a total of 575 g in the female patient undergoing the bilateral thigh lift. Intraoperatively, no complications occurred, and the median postoperative hospital length of stay was 12.5 days (7 to 20 days).

3.2. Complications in Patients Undergoing Body Contouring Surgery After Single Organ Transplantation

Postoperatively, one patient had an uneventful course and was discharged after seven days. The next patient developed small dermal purpura postoperatively, which was diagnosed as thrombophilic vasculitis. This was most likely attributable to a preoperatively unrecognized APC resistance. As the symptoms were self-limiting, no further therapeutic intervention was necessary (Grade I).
In the same patient, an abscess formation was found in the lower pelvis, which was then treated with an antibiotic course (Grade II). Both complications were not related to the initial surgical procedure. Another patient caught a respiratory infection, with leukocytosis of 12.3 G/L and an elevated C-reactive protein level of 13.1 mg/dL, so an intravenous antibiotic course was started and continued orally after discharge. This was graded as Grade I.
The next patient had a prolonged postoperative seroma, with the drains kept until the 11th postoperative day, which was classified as a Grade I complication. No abnormal elevations were observed in the patient’s laboratory findings.
None of these patients suffered other complications within the first four weeks of the postoperative period (Table 2).

4. Discussion

It can be assumed that the number of patients undergoing transplantation and body contouring surgery afterwards is going to increase. Both bariatric surgery and body contouring surgery seem to improve the quality of life postoperatively in patients dealing with excess skin [24,25,33].
So far, there is little data on patients with single organ transplantation undergoing body contouring procedures and whether they are more likely to have postoperative complications [31,34]. In a recent work, published by Iannelli et al., the outcome of a liver transplantation was not affected by previous BS [35]. However, patients after BS undergoing BCP do have reported complication rates up to 37% [36,37]. This includes minor complications like seroma or wound dehiscence, which partially correlates with our findings.
A meta-analysis performed by Hasanbegovic et al. showed that in post-bariatric patients undergoing BCP, the risk of a complication increases by 60% compared to patients who lost weight due to other reasons [38]. If transplantation is required, obesity can be associated with organ damage and therefore a progression of its failure, while an increased BMI prolongs the patient’s time listed for transplantation [39]. Dziodzio et al. state that bariatric surgery is a valuable surgical option for obese patients facing kidney transplantation or even for organ recipients [20], especially because some patients after SOT gain 30% of their body weight within three years after transplantation [40]. For that reason, BS should be considered to reduce body weight in order to prevent transplant failure [22].
On the other hand, standard surgical incisions for SOT can compromise the blood supply of the abdominal wall and make subsequent procedures (e.g., an abdominoplasty) technically more demanding [41,42,43]. When considering a transplant patient for BCP, a key factor possibly impeding the operative results is an ongoing immunosuppressive therapy. Although these regimens vary between transplant centers, most often calcineurin inhibitors, mycophenolate mofetil and corticosteroids are used [44].
In the current literature, wound healing complications after kidney transplantation are reported in up to 27% of the patients [45,46,47]. Corticosteroids are especially associated with an impairment of wound healing [48]. We were not able to correlate these findings in our study due to the low patient numbers.
Another recent publication compared the quality of life in post-bariatric patients who underwent body contouring surgery (e.g., abdominoplasty or panniculectomy) to post-bariatric patients who did not have BCP. The authors were able to show a significant improvement in the quality of life in these patients, measured with the BODY-Q score [25]. Similar results with a two-year follow-up period were shown by Song et al., where the authors were able to demonstrate that bariatric surgery and body contouring surgery can enhance the quality of life and body image in these patients [49].
Among our patients, one patient had undergone kidney transplantation—which is statistically the most commonly performed single organ transplantation [50]. Before undergoing BCP, some patients were already weaned off the standard triple immunosuppression, with one patient even being weaned off his immunosuppressive therapy completely. As mentioned above, most of our patients underwent dermolipectomy to not jeopardize the blood supply of the abdominal wall after a SOT had already been performed.
Although we included patients from the past ten years, this single-center study comprises a small case series; yet, complication rates seem to correlate with other publications already available. Study limitations include the low patient number and the retrospective study design. While no major complications were observed in our cohort, this limited number precludes a robust and generalizable assessment of the safety profile of body contouring procedures in transplant patients.
Larger, prospective, and ideally multicenter studies are needed to more comprehensively characterize the safety profile, identify potential risk factors for complications, and establish more definitive conclusions regarding the overall risk–benefit ratio of this approach. Future studies should therefore incorporate extended follow-up periods together with patient-reported outcome measures, as these would provide a more comprehensive understanding of how body contouring surgery affects quality of life and functional status in this specific patient population.
Future studies should also address the effect of the pharmacological treatment of obesity, with Obesity Management Medication, to study its effect on wound healing in patients who underwent single organ transplantation [51,52].

5. Conclusions

Body contouring surgery appears to be a safe procedure in patients who have undergone single organ transplantation, with complication rates comparable to those reported in the general post-bariatric population. As the number of transplant recipients seeking body contouring procedures continues to rise, these patients should not be categorically excluded from surgical candidacy. However, due to the complexity of this cohort, management should be conducted at tertiary centers with close interdisciplinary collaboration between plastic, transplant, and internal medicine specialists.

Author Contributions

Conceptualization, P.T.-F., E.P.-G. and C.R.; methodology, P.T.-F.; formal analysis, P.T.-F.; investigation, P.T.-F., A.W. and E.P.-G.; data curation, P.T.-F., A.W., C.F. and E.P.-G.; writing—original draft preparation, P.T.-F. and E.P.-G.; writing—review and editing, P.T.-F., A.W., C.F., E.P.-G. and C.R.; supervision, E.P.-G. and C.R.; project administration, P.T.-F., E.P.-G. and C.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board and Ethics Committee of the Medical University of Vienna (protocol number 1836/2021, approved 28 October 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data supporting the conclusions of this article will be made available by the authors on reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BCPBody contouring procedure
SOTSingle organ transplantation
BSBariatric surgery

References

  1. Madsen, H.J.; Gillette, R.A.; Colborn, K.L.; Henderson, W.G.; Dyas, A.R.; Bronsert, M.R.; Lambert-Kerzner, A.; Meguid, R.A. The association between obesity and postoperative outcomes in a broad surgical population: A 7-year American College of Surgeons National Surgical Quality Improvement analysis. Surgery 2023, 173, 1213–1219. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Gurunathan, U.; Rapchuk, I.L.; Dickfos, M.; Larsen, P.; Forbes, A.; Martin, C.; Leslie, K.; Myles, P.S. Association of Obesity With Septic Complications After Major Abdominal Surgery: A Secondary Analysis of the RELIEF Randomized Clinical Trial. JAMA Netw. Open 2019, 2, e1916345. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Collaborative, S.T. Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery. Br. J. Surg. 2016, 103, 1157–1172. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Wang, H.P.; Gaddis, C.; Bayless, M.; Hollman, N.; Williams, J.; Alamiri, N.; Khorgami, Z. Impact of obesity on the outcomes of panniculectomy and abdominoplasty: An ACS-NSQIP analysis. J. Plast. Reconstr. Aesthet. Surg. 2025, 106, 286–293. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Doyle, S.L.; Lysaght, J.; Reynolds, J.V. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes. Rev. 2010, 11, 875–886. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Kwong, A.J.; Kim, W.R.; Lake, J.R.; Schladt, D.P.; Handarova, D.; Howell, J.; Schumacher, B.; Weiss, S.; Snyder, J.J.; Israni, A.K. OPTN/SRTR 2023 Annual Data Report: Liver. Am. J. Transplant. 2025, 25, S193–S287. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Lentine, K.L.; Smith, J.M.; Lyden, G.R.; Miller, J.M.; Booker, S.E.; Dolan, T.G.; Temple, K.R.; Weiss, S.; Handarova, D.; Israni, A.K.; et al. OPTN/SRTR 2023 Annual Data Report: Kidney. Am. J. Transplant. 2025, 25, S22–S137. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Younossi, Z.M.; Germani, G.; Wong, R.; Stepanova, M.; Nader, F.; Karam, V.; Adam, R.; Alqahtani, S.A.; Henry, L.; Burra, P. Steatotic liver disease is the dominant indication for liver transplantation in both Europe and the United States: Trends and outcomes in the past 2 decades. Liver Transplant. 2026, 32, 549–557. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Wong, R.J.; Aguilar, M.; Cheung, R.; Perumpail, R.B.; Harrison, S.A.; Younossi, Z.M.; Ahmed, A. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015, 148, 547–555. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Stepanova, M.; Kabbara, K.; Mohess, D.; Verma, M.; Roche-Green, A.; AlQahtani, S.; Ong, J.; Burra, P.; Younossi, Z.M. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients. Hepatol. Commun. 2022, 6, 1506–1515. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Goldberg, D.; Ditah, I.C.; Saeian, K.; Lalehzari, M.; Aronsohn, A.; Gorospe, E.C.; Charlton, M. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology 2017, 152, 1090–1099 e1091. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Muller, P.C.; Kabacam, G.; Vibert, E.; Germani, G.; Petrowsky, H. Current status of liver transplantation in Europe. Int. J. Surg. 2020, 82S, 22–29. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Chen, T.K.; Knicely, D.H.; Grams, M.E. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA 2019, 322, 1294–1304. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Lim, W.H.; Wong, G.; Pilmore, H.L.; McDonald, S.P.; Chadban, S.J. Long-term outcomes of kidney transplantation in people with type 2 diabetes: A population cohort study. Lancet Diabetes Endocrinol. 2017, 5, 26–33. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Herrington, W.G.; Judge, P.K.; Grams, M.E.; Wanner, C. Chronic kidney disease. Lancet 2026, 407, 90–104. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Webster, A.C.; Nagler, E.V.; Morton, R.L.; Masson, P. Chronic Kidney Disease. Lancet 2017, 389, 1238–1252. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Landsberg, L.; Aronne, L.J.; Beilin, L.J.; Burke, V.; Igel, L.I.; Lloyd-Jones, D.; Sowers, J. Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension. Obesity 2013, 21, 8–24. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. Rinella, M.E.; Neuschwander-Tetri, B.A.; Siddiqui, M.S.; Abdelmalek, M.F.; Caldwell, S.; Barb, D.; Kleiner, D.E.; Loomba, R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023, 77, 1797–1835. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  19. Lingvay, I.; Cohen, R.V.; Roux, C.W.L.; Sumithran, P. Obesity in adults. Lancet 2024, 404, 972–987. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Dziodzio, T.; Biebl, M.; Ollinger, R.; Pratschke, J.; Denecke, C. The Role of Bariatric Surgery in Abdominal Organ Transplantation-the Next Big Challenge? Obes. Surg. 2017, 27, 2696–2706. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  21. Verhoeff, K.; Dang, J.T.; Modasi, A.; Switzer, N.; Birch, D.W.; Karmali, S. Bariatric Surgery Outcomes in Patients with Previous Organ Transplant: Scoping Review and Analysis of the MBSAQIP. Obes. Surg. 2021, 31, 508–516. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Ashby, V.B.; Leichtman, A.B.; Rees, M.A.; Song, P.X.; Bray, M.; Wang, W.; Kalbfleisch, J.D. A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size. Clin. J. Am. Soc. Nephrol. 2017, 12, 1148–1160. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  23. Kitzinger, H.B.; Abayev, S.; Pittermann, A.; Karle, B.; Kubiena, H.; Bohdjalian, A.; Langer, F.B.; Prager, G.; Frey, M. The prevalence of body contouring surgery after gastric bypass surgery. Obes. Surg. 2012, 22, 8–12. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Buer, L.; Kvalem, I.L.; Bardstu, S.; Mala, T. Comparing Bariatric Surgery Patients Who Desire, Have Undergone, or Have No Desire for Body Contouring Surgery: A 5-Year Prospective Study of Body Image and Mental Health. Obes. Surg. 2022, 32, 2952–2959. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Elfanagely, O.; Rios-Diaz, A.J.; Cunning, J.R.; Othman, S.; Morris, M.; Messa, C.t.; Broach, R.B.; Fischer, J.P. A Prospective, Matched Comparison of Health-Related Quality of Life in Bariatric Patients following Truncal Body Contouring. Plast. Reconstr. Surg. 2022, 149, 1338–1347. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Sirota, M.; Weiss, A.; Billig, A.; Hassidim, A.; Zaga, J.; Adler, N. Abdominoplasty complications—What additional risks do postbariatric patients carry? J. Plast. Reconstr. Aesthet. Surg. 2021, 74, 3415–3420. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Wu, C.; Evans, I.; Joseph, R.; Shapiro, R.; Tan, H.; Basu, A.; Smetanka, C.; Khan, A.; McCauley, J.; Unruh, M. Comorbid conditions in kidney transplantation: Association with graft and patient survival. J. Am. Soc. Nephrol. 2005, 16, 3437–3444. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  28. Ehrsam, J.P.; Schuurmans, M.M.; Laager, M.; Opitz, I.; Inci, I. Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation. Transplant. Int. 2022, 35, 10451. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  29. Hartrampf, C.R.; Scheflan, M.; Black, P.W. Breast reconstruction with a transverse abdominal island flap. Plast. Reconstr. Surg. 1982, 69, 216–225. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Holm, C.; Mayr, M.; Hofter, E.; Ninkovic, M. Perfusion zones of the DIEP flap revisited: A clinical study. Plast. Reconstr. Surg. 2006, 117, 37–43. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. Zellner, E.; Lentz, R. Complications Following Plastic Surgery in Solid Organ Transplant Recipients: A Descriptive Cohort Study. J. Aesthetic Reconstr. Surg. 2016, 2, 10. [Google Scholar] [CrossRef]
  32. Dindo, D.; Demartines, N.; Clavien, P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Berkane, Y.; Saget, F.; Lupon, E.; Mocquard, C.; Pluvy, I.; Watier, E.; Lellouch, A.G.; Duisit, J.; Chaput, B.; Bertheuil, N. Abdominoplasty and lower body lift surgery improves the quality of life after massive weight loss: A prospective multicenter study. Plast. Reconstr. Surg. 2023, 153, 1101e–1110e. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Sweis, I.; Tzvetanov, I.; Benedetti, E. The new face of transplant surgery: A survey on cosmetic surgery in transplant recipients. Aesthetic Plast. Surg. 2009, 33, 819–826; discussion 827. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  35. Iannelli, A.; Bulsei, J.; Debs, T.; Tran, A.; Lazzati, A.; Gugenheim, J.; Anty, R.; Petrucciani, N.; Fontas, E. Clinical and Economic Impact of Previous Bariatric Surgery on Liver Transplantation: A Nationwide, Population-Based Retrospective Study. Obes. Surg. 2022, 32, 55–63. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  36. De Paep, K.; Van Campenhout, I.; Van Cauwenberge, S.; Dillemans, B. Post-bariatric Abdominoplasty: Identification of Risk Factors for Complications. Obes. Surg. 2021, 31, 3203–3209. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  37. Michaels, J.T.; Coon, D.; Rubin, J.P. Complications in postbariatric body contouring: Postoperative management and treatment. Plast. Reconstr. Surg. 2011, 127, 1693–1700. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  38. Hasanbegovic, E.; Sorensen, J.A. Complications following body contouring surgery after massive weight loss: A meta-analysis. J. Plast. Reconstr. Aesthet. Surg. 2014, 67, 295–301. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  39. Segev, D.L.; Simpkins, C.E.; Thompson, R.E.; Locke, J.E.; Warren, D.S.; Montgomery, R.A. Obesity impacts access to kidney transplantation. J. Am. Soc. Nephrol. 2008, 19, 349–355. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  40. Richards, J.; Gunson, B.; Johnson, J.; Neuberger, J. Weight gain and obesity after liver transplantation. Transplant. Int. 2005, 18, 461–466. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  41. Mahabbat, N.A.; Shah Mardan, Q.N.M.; Mohamed, A.O.; Almarshad, F.A.; Mrad, M.A.; Al-Qattan, M.M.; Hashem, F.K. Challenging the Subcostal Incision Scar with the Two-staged Abdominoplasty: An Innovative Approach. Plast. Reconstr. Surg. Glob. Open 2022, 10, e4047. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  42. Donataccio, M.; Genco, B.; Donataccio, D. Right subcostal incision in liver transplantation: Prospective study of feasibility. Transplant. Proc. 2006, 38, 1109–1110. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  43. Rieger, U.M.; Aschwanden, M.; Schmid, D.; Kalbermatten, D.F.; Pierer, G.; Haug, M. Perforator-sparing abdominoplasty technique in the presence of bilateral subcostal scars after gastric bypass. Obes. Surg. 2007, 17, 63–67. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  44. Pilch, N.A.; Bowman, L.J.; Taber, D.J. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy 2021, 41, 119–131. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  45. Roine, E.; Bjork, I.T.; Oyen, O. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant. Proc. 2010, 42, 2542–2546. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  46. Lau, N.S.; Ahmadi, N.; Verran, D. Abdominal wall complications following renal transplantation in adult recipients—Factors associated with interventional management in one unit. BMC Surg. 2019, 19, 10. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  47. Santangelo, M.; De Rosa, P.; Spiezia, S.; Spinosa, G.; Grassia, S.; Zuccaro, M.; Renda, A. Healing of surgical incision in kidney transplantation: A single transplant center’s experience. Transplant. Proc. 2006, 38, 1044–1046. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  48. Wang, A.S.; Armstrong, E.J.; Armstrong, A.W. Corticosteroids and wound healing: Clinical considerations in the perioperative period. Am. J. Surg. 2013, 206, 410–417. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  49. Song, P.; Patel, N.B.; Gunther, S.; Li, C.S.; Liu, Y.; Lee, C.Y.; Kludt, N.A.; Patel, K.B.; Ali, M.R.; Wong, M.S. Body Image & Quality of Life: Changes With Gastric Bypass and Body Contouring. Ann. Plast. Surg. 2016, 76, S216–S221. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  50. Martin, F.; Carmona, M.; Mahillo, B.; Alvarez, M.; Luengo, A.; Chatzixiros, E.; Lopez-Fraga, M.; Dominguez-Gil, B.; Tullius, S.G. Organ Donation and Transplantation Worldwide: The Global Observatory on Donation and Transplantation 2024 Report. Transplantation 2026, 110, e655–e669. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  51. American Diabetes Association Professional Practice Committee for Obesity. Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity. BMJ Open Diabetes Res. Care 2026, 13, e005729. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  52. Lee, C.C.; Newland, M.; Yau, A.; Chroneos, R.; Johnson, T.S. Impact of GLP-1 Agonist on Surgical Wound Complications Following Plastic and Reconstructive Surgery: A Propensity Matched Cohort Large Database Analysis. Plast. Reconstr. Surg. 2025. Epub ahead of printing. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Figure 1. A 49-year-old male patient with a history of kidney transplantation and subsequent gastric sleeve gastrectomy resulting in 30 kg weight loss, who underwent abdominoplasty. Preoperative view (left) and postoperative result at 12 weeks (right). Red arrows indicate the scar from a kidney transplantation performed 37 months prior to body contouring surgery.
Figure 1. A 49-year-old male patient with a history of kidney transplantation and subsequent gastric sleeve gastrectomy resulting in 30 kg weight loss, who underwent abdominoplasty. Preoperative view (left) and postoperative result at 12 weeks (right). Red arrows indicate the scar from a kidney transplantation performed 37 months prior to body contouring surgery.
Jcm 15 06549 g001
Table 1. Patient demographics. SOT (single organ transplantation), IS (immunosuppressive regiment), BS (bariatric surgery), and BMI (body mass index).
Table 1. Patient demographics. SOT (single organ transplantation), IS (immunosuppressive regiment), BS (bariatric surgery), and BMI (body mass index).
PatientAgeGenderSOTIS PreoperativelyBSComorbiditiesSmokingBMI
#156 yMaleLiverFK-506Gastric Sleeve≤3Unknown26.3
#251 yFemaleLiverCyclosporineNone>3No23.8
#328 yMaleHeartNoneGastric Sleeve>3No28.4
#449 yMaleKidneyFK-506, MMF, SteroidsGastric Sleeve>3No22.3
Table 2. Body contouring procedure (BCP) and complications, classified according to Clavien and Dindo, and length of hospital stay (LOS).
Table 2. Body contouring procedure (BCP) and complications, classified according to Clavien and Dindo, and length of hospital stay (LOS).
PatientBCPResection Weight (g)ComplicationsClassificationLOS (d)
#1Abdominal
dermolipectomy
1084NoneN/A7
#2Bilateral thigh lift575Thrombophilic vasculitis,
Pelvic abscess formation
Grade I
Grade II
20
#3Abdominal
dermolipectomy
380Respiratory infectGrade II9
#4Abdominoplasty1200Prolonged postoperative seromaGrade I14
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tratnig-Frankl, P.; Wiland, A.; Freystätter, C.; Placheta-Györi, E.; Radtke, C. Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience. J. Clin. Med. 2026, 15, 6549. https://doi.org/10.3390/jcm15176549

AMA Style

Tratnig-Frankl P, Wiland A, Freystätter C, Placheta-Györi E, Radtke C. Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience. Journal of Clinical Medicine. 2026; 15(17):6549. https://doi.org/10.3390/jcm15176549

Chicago/Turabian Style

Tratnig-Frankl, Philipp, Andrea Wiland, Christian Freystätter, Eva Placheta-Györi, and Christine Radtke. 2026. "Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience" Journal of Clinical Medicine 15, no. 17: 6549. https://doi.org/10.3390/jcm15176549

APA Style

Tratnig-Frankl, P., Wiland, A., Freystätter, C., Placheta-Györi, E., & Radtke, C. (2026). Solid Organ Transplantation and Body Contouring Surgery: A Case Series and Single-Center Experience. Journal of Clinical Medicine, 15(17), 6549. https://doi.org/10.3390/jcm15176549

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop